See every side of every news story
Published loading...Updated

Long-Term Ixekizumab Treatment Does Not Raise Risk for Cancer in Patients With Chronic Inflammatory Disease

Summary by Medscape
Long-term treatment with ixekizumab does not increase the incidence of malignant neoplasms in patients with psoriasis, PsA, and axSpA, according to a pooled analysis of randomized trials.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Medscape broke the news in United States on Wednesday, July 9, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.